Zafgen, Inc.

📍 Boston, United States🗓 Founded 2005👥 23 employees💰 Last funded Sep 2015
Biotechnology🌐 zafgen.com
Website LinkedIn
Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Zafgen, Inc.?
Zafgen, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers.
When did Zafgen, Inc. last raise funding?
The most recent investment in Zafgen, Inc. recorded on gritt.io was in September 2015.
When was Zafgen, Inc. founded?
Zafgen, Inc. was founded in 2005.
What industry is Zafgen, Inc. in?
Zafgen, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Zafgen, Inc. based?
Zafgen, Inc. is headquartered in Boston, United States.